Mizuho analyst Steven Valiquette raised the firm’s price target on McKesson (MCK) to $690 from $630 and keeps a Neutral rating on the shares. McKesson closed its acquisition of Prism Vision on Wednesday, and Mizuho expects the company to close its pending $2.5B majority stake acquisition in Florida Cancer Specialists “soon,” the analyst tells investors in a research note. The firm is modeling 45c-50c accretion from 9-10 months of FCS in the new fiscal 2026 EPS estimate of $37.00.
https://www.tipranks.com/news/the-fly/mckesson-price-target-raised-to-690-from-630-at-mizuho
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.